Abstract
Purpose. Side effects of diarrhea and steatorrhea diminish the therapeutic value of highly active antiretroviral therapy (HAART). We report in vitro studies of the effect of HAART drugs on the activity of pancrelipase, trypsin, and enterokinase and restoration of activity by subsequent addition of excess pancrelipase or colipase.
Methods. Commercial formulations of sixteen HAART drug formulations with solvent and four excipients were mixed with substrate. Activity of pancrelipase was recorded after addition of the enzyme; restoration of activity was monitored after addition of excess pancrelipase or colipase to the reaction mixture.
Results. Five protease inhibitors (Agenerase solution, Agenerase capsules, Norvir, Viracept, Kaletra, and Fortovase) and the excipient TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate) inhibited lipase significantly at or below physiological concentrations. Neither nucleoside reverse transcriptase inhibitors nor non-nucleoside reverse transcriptase inhibitors showed significant lipase inhibition at physiological levels. Addition of excess pancrelipase to the medium completely reversed inhibition by Agenerase, Fortovase, Norvir, and TPGS and reactivated lipase; it diminished inhibition by Kaletra and Viracept but did not completely restore activity. Addition of colipase reversed inhibition by Agenerase solution, Agenerase capsules, and TPGS; inhibition by Kaletra and Fortovase recovered slightly. No compounds tested inhibited trypsin or enterokinase.
Conclusions. These results justify evaluating protocols involving coadministration of buffered pancrelipase with protease inhibitors to reduce or eliminate diarrhea and steatorrhea in individuals being treated for HIV.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. Miller, S. Staszewski, C. Sabin, A. Carlebach, C. Rottmann, E. Weidemann, H. Rabenau, A. Hill, A. C. Lepri, and A. N. Phillips. CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load. J. Infect. Dis. 180:530-533 (1999).
B. Autran, G. Caprcelain, T. Li, C. Blanc, D. Mathez, R. Tubiana, C. Katlama, P. Debre, and J. Leibowitch. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112-116 (1997).
S. A. Call, G. Heudebert, M. Saag, and C. M. Wilcox. The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3. Am. J. Gastroenterol. 95:3142-3146 (2000).
M. A. Poles, M. Fuerst, I. McGowan, J. Elliott, A. Rezaei, D. Mark, P. Taing, and P. A. Anton. HIV-related diarrhea is multifactorial and fat malabsorption is commonly present, independent of HAART. Am. J. Gastroenterol. 96:1831-1837 (2001).
D. S. Sherman and D. N. Fish. Management of protease inhibitor-associated diarrhea. Clin. Infect. Dis. 30:908-914 (2000).
D. Voet and J. G. Voet. Biochemistry, 3rd ed. John Wiley & Sons, Hoboken, NJ, 2004, pp. 527-528, 910-911.
R. Guerciolini. Mode of action of orlistat. Int. J. Obes. Relat. Metab. Disord. 21:S12-S23 (1997).
L. M. Tierney Jr., S. J. McPhee, and M. A. Papadak (eds). Current Medical Diagnosis and Treatment 2000, 39th ed. Lange Medical Books/McGraw-Hill, New York, 2000, pp. 561,613,694.
U. S. Pharmacopoeia XXIV/ National Formulary XIX 2000. United States Pharmacopeial Convention, Inc., Rockville, MD, 2000, p. 1255.
Physician's Desk Reference 2000, 54th ed., Thomson PDR, Montvale, NJ, 2000, p. 2696.
W. Junge, K. Leybold, and B. Kraack. Influence of colipase on the turbidimetric determination of pancreatic lipase catalytic activity. J. Clin. Chem. Clin. Biochem. 21:445-451 (1983).
H. U. Bergmeyer (ed.). Methods of Enzymatic Analysis, 5(3):121-123 (1984). Academic Press, New York.
Biozyme Laboratories International Limited. Test procedure for enterokinase EK-2B freeze dried powder. Biozyme Laboratories International Limited, San Diego, CA, 1995.
H. Cavaliere, I. Floriano, and G. Medeiros-Neto. Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid). Int. J. Obes. Relat. Metab. Disord. 25:1095-1099 (2001).
J. Hermoso, D. Pignol, B. Kerfelec, I. Crenon, C. Chapus, and J. Fontecilla-Camps. Lipase activation by nonionic detergents. J. Biol. Chem. 271:18007-18016 (1996).
J. Hermoso, D. Poignol, S. Penel, M. Roth, C. Chapus, and J. C. Fontecilla-Camps. Neutron crystallographic evidence of lipase-colipase complex activation by a micelle. EMBO J. 16:5531-5536 (1997).
L. Ayvazian, I. Crenon, J. Hermoso, D. Pignol, C. Chapus, and B. Kerfelec. Ion pairing between lipase and colipase plays a critical role in catalysis. J. Biol. Chem. 273:33604-33609 (1998).
D. Pignol, I. Ayvazian, B. Kerfelec, P. Timmins, I. Crenon, J. Hermoso, J. C. Fontecilla-Camps, and C. Chapus. Critical role of micelles in pancreatic lipase activation revealed by small angle neutron scattering. J. Biol. Chem. 275:4220-4224 (2000).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wignot, T.M., Stewart, R.P., Schray, K.J. et al. In Vitro Studies of the Effects of HAART Drugs and Excipients on Activity of Digestive Enzymes. Pharm Res 21, 420–427 (2004). https://doi.org/10.1023/B:PHAM.0000019294.03188.cf
Issue Date:
DOI: https://doi.org/10.1023/B:PHAM.0000019294.03188.cf